Microalgae fermentation unlocks sustainable and nutritious food production, offering bioactive peptides with antidiabetic properties but faces challenges in consumer acceptance.
Takeda wins long-awaited US approval for first oral drug for eosinophilic esophagitis
The FDA on Monday approved Takeda’s Eohilia, the first oral drug for patients with eosinophilic esophagitis (EoE) in the US, which the company briefly abandoned
February 13, 2024